POSITION:CODVIP|Winner7777|Winner777 Online Casino|Download Win777 > Winner7777 >
GENEVA, Switzerland — The World Health Organization (WHO) on Tuesday approved an mpox vaccine from Japanese pharmaceutical company KM Biologics for emergency use, the second one to get the agency’s seal of approval.
The WHO said it granted emergency use listing (EUL) authorization to the LC16m8 vaccine to “facilitate increased and timely access to vaccines in communities where mpox outbreaks are surging.”
Article continues after this advertisementA WHO EUL paves the way for countries worldwide to approve and import the vaccine for distribution quickly.
FEATURED STORIES GLOBALNATION Customs broker, 2 others guilty over shipment of P6.4B shabu GLOBALNATION Marcos says he had 'friendly, productive' phone call with Trump GLOBALNATION Mary Jane Veloso's transfer to PH facility under discussion – DFA“WHO emergency use listing of the LC16m8 vaccine against mpox marks a significant step in our response to the current emergency, providing a new option to protect all populations, including children,” Yukiko Nakatani, WHO’s assistant director-general for access to medicines and health products, said in a statement.
READ: Mpox: What is it, how it spreads, care for patients
Article continues after this advertisementThe WHO had already in September prequalified another vaccine against mpox, Bavarian-Nordic’s MVA-BN, in a bid to help step up the fight against swelling mpox outbreaks.
Article continues after this advertisementThe UN health agency on August 14 declared a fresh international emergency over mpox, amid mounting concern over a surge in cases of the new Clade 1b strain in the Democratic Republic of Congo that spread to nearby countries.
Article continues after this advertisementThat and other mpox strains have been reported across 80 countries – 19 of them in Africa – so far this year, WHO said.
The DR Congo remains by far the hardest-hit country, having recorded a large majority of the more than 39,000 suspected cases and over 1,000 deaths.
Article continues after this advertisementWHO said that Tuesday’s announcement was particularly relevant since the Japanese government had announced it would donate 3.05 million LC16m8 doses along with specialised inoculation needles to the DRC.
READ: WHO launches $135-M response plan vs mpox
“This is the largest donation package announced to date in response to the current mpox emergency,” it said.
The WHO warned the vaccine should not be used during pregnancy or by immunocompromised persons.
Mpox, previously known as monkeypox, is caused by a virus transmitted to humans by infected animals but can also be passed from human to human through close physical contact.
Subscribe to our daily newsletter
It causes fever, muscular aches and large boil-like skin lesionskkbet, and can be deadly.
READ NEXT Prosecutors open to new Trump sentencing delay Marcos revives his hope for peace in Ukraine EDITORS' PICK Marcos calls to congratulate Trump, cites Fil-Am votes he got Adopt AI or perish Kris Aquino grateful as son Josh recovers from COVID-19 SCHEDULE: Gilas Pilipinas at Fiba Asia Cup 2025 qualifiers Roger Federer pens tribute to retiring Rafael Nadal US, PH alliance to ‘transcend’ changes of administration – Austin MOST READ 117 senatorial hopefuls disqualified for being nuisance candidates BIZ BUZZ: RCBC changing of the guard Japan discovers $26,290,780,000 worth of rare earth metals Adopt AI or perish Follow @FMangosingINQ on Twitter --> View commentsHot News
Related News